Our research has been built on a history of excellence. We conduct basic, clinical, and outcomes research. Visit our research sections below for more information.
Salim Hayek, MD and Subramaniam Pennathur, MD find that hospitalized patients with COVID have high levels of soluble urokinase receptor, a strong predictor of kidney injury.
Matthias Kretzler, MD and team receive a grant to study the therapeutic potential of anti-interleukin 6 agents to treat kidney cells in COVID-19 patients.
Listen to Michigan Medicine's team of researchers from various disciplines discuss finding new treatments and new ways to prevent diabetic complications including diabetic kidney disease, diabetic neuropathy, and diabetic retinopathy.